HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+14.9%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$272M
AUM Growth
+$272M
(+4.9%)
Cap. Flow
-$12.8M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
27.33%
Holding
177
New
29
Increased
50
Reduced
55
Closed
31
Top Buys
| 1 |
Viridian Therapeutics
VRDN
|
$4.25M |
| 2 |
Advanced Micro Devices
AMD
|
$2.19M |
| 3 |
Celldex Therapeutics
CLDX
|
$2.17M |
| 4 |
Ferguson
FERG
|
$2.15M |
| 5 |
Mineralys Therapeutics
MLYS
|
$2.03M |
Top Sells
| 1 |
Albertsons Companies
ACI
|
$4.15M |
| 2 |
GE Vernova
GEV
|
$3.07M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$3.03M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$2.1M |
| 5 |
Bausch Health
BHC
|
$2.03M |
Sector Composition
| 1 | Healthcare | 37.62% |
| 2 | Technology | 22.09% |
| 3 | Industrials | 8.52% |
| 4 | Financials | 6.08% |
| 5 | Consumer Discretionary | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Structure Therapeutics
GPCR
$1.11B
| $1.8M | 0.66% | 86,621 +69,060 | +393% | +$1.43M |
|
|
SNDK
52
Sandisk Corporation Common Stock
SNDK
$7.65B
| $1.8M | 0.66% | +39,600 | New | +$1.8M |
|
53
Rhythm Pharmaceuticals
RYTM
$6.85B
| $1.77M | 0.65% | 28,068 -6,971 | -20% | -$440K |
|
54
Hewlett Packard
HPE
$29.6B
| $1.76M | 0.65% | 86,200 -47,300 | -35% | -$967K |
|
55
PTC
PTC
$25.6B
| $1.74M | 0.64% | 10,122 +41 | +0.4% | +$7.07K |
|
|
TLN
56
Talen Energy Corporation Common Stock
TLN
$17.3B
| $1.72M | 0.63% | 5,900 -1,800 | -23% | -$523K |
|
57
Spyre Therapeutics
SYRE
$996M
| $1.69M | 0.62% | 112,805 +17,646 | +19% | +$264K |
|
58
Entegris
ENTG
$12.7B
| $1.69M | 0.62% | +20,900 | New | +$1.69M |
|
59
Cisco
CSCO
$274B
| $1.64M | 0.6% | 23,600 -8,600 | -27% | -$597K |
|
60
Progressive
PGR
$145B
| $1.57M | 0.58% | 5,900 +900 | +18% | +$240K |
|
61
Bank of America
BAC
$376B
| $1.54M | 0.57% | +32,600 | New | +$1.54M |
|
62
Delta Air Lines
DAL
$40.3B
| $1.51M | 0.56% | 30,800 | – | – |
|
63
Alkermes
ALKS
$4.78B
| $1.51M | 0.56% | 52,944 -17,818 | -25% | -$510K |
|
64
Liquidia Corp
LQDA
$2.38B
| $1.5M | 0.55% | 120,641 -82,869 | -41% | -$1.03M |
|
65
Apellis Pharmaceuticals
APLS
$3.48B
| $1.5M | 0.55% | 86,663 -22,051 | -20% | -$382K |
|
66
Charles Schwab
SCHW
$174B
| $1.49M | 0.55% | +16,300 | New | +$1.49M |
|
67
Guardant Health
GH
$8.41B
| $1.47M | 0.54% | 28,265 -23,453 | -45% | -$1.22M |
|
68
Workday
WDAY
$61.6B
| $1.46M | 0.54% | 6,100 +500 | +9% | +$120K |
|
69
Janux Therapeutics
JANX
$1.37B
| $1.44M | 0.53% | 62,436 -12,120 | -16% | -$280K |
|
70
Royal Caribbean
RCL
$98.7B
| $1.44M | 0.53% | 4,600 -4,200 | -48% | -$1.32M |
|
71
CME Group
CME
$96B
| $1.43M | 0.53% | +5,200 | New | +$1.43M |
|
72
Sea Limited
SE
$110B
| $1.43M | 0.53% | 8,941 -1,700 | -16% | -$272K |
|
73
Xenon Pharmaceuticals
XENE
$2.98B
| $1.43M | 0.52% | 45,620 -21,168 | -32% | -$663K |
|
74
RBC Bearings
RBC
$12.3B
| $1.42M | 0.52% | 3,700 +300 | +9% | +$115K |
|
75
TKO Group
TKO
$15.6B
| $1.38M | 0.51% | 7,600 -1,600 | -17% | -$291K |
|